These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25951069)

  • 1. Inverse relationship between soluble urokinase receptors and estimated glomerular filtration rate: a role for IL-2?
    Shin JI
    Kidney Int; 2015 May; 87(5):1074. PubMed ID: 25951069
    [No Abstract]   [Full Text] [Related]  

  • 2. suPAR and focal segmental glomerulosclerosis.
    Praga M
    Nefrologia; 2014; 34(2):145-8. PubMed ID: 24658189
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.
    Sinha A; Bajpai J; Saini S; Bhatia D; Gupta A; Puraswani M; Dinda AK; Agarwal SK; Sopory S; Pandey RM; Hari P; Bagga A
    Kidney Int; 2014 Mar; 85(3):649-58. PubMed ID: 24429405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The authors reply.
    Bagga A; Sinha A
    Kidney Int; 2015 May; 87(5):1074. PubMed ID: 25951071
    [No Abstract]   [Full Text] [Related]  

  • 5. Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?
    Schlöndorff D
    Kidney Int; 2014 Mar; 85(3):499-501. PubMed ID: 24583981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated soluble urokinase receptors in focal segmental glomerulosclerosis: a role for IL-2?
    Park SJ; Saleem MA; Shin JI
    Kidney Int; 2014 Jun; 85(6):1469-70. PubMed ID: 24875551
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum-soluble urokinase receptor concentration in primary FSGS.
    Maas RJH; Wetzels JFM; Deegens JKJ
    Kidney Int; 2012 May; 81(10):1043-1044. PubMed ID: 22543906
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis.
    Harita Y; Ishizuka K; Tanego A; Sugawara N; Chikamoto H; Akioka Y; Tsurumi H; Miura K; Gotoh Y; Tsujita M; Yamamoto T; Horike K; Takeda A; Oka A; Igarashi T; Hattori M
    Pediatr Nephrol; 2014 Sep; 29(9):1553-60. PubMed ID: 24705794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View.
    Kronbichler A; Saleem MA; Meijers B; Shin JI
    J Immunol Res; 2016; 2016():2068691. PubMed ID: 27504461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum suPAR concentrations in patients with focal segmental glomerulosclerosis with end-stage renal disease.
    Maas RJ; Wetzels JF; Deegens JK
    Kidney Int; 2014 Mar; 85(3):711. PubMed ID: 24583989
    [No Abstract]   [Full Text] [Related]  

  • 11. Glomerular disease: 'suPAR'-exciting times for FSGS.
    Jefferson JA; Alpers CE
    Nat Rev Nephrol; 2013 Mar; 9(3):127-8. PubMed ID: 23381372
    [No Abstract]   [Full Text] [Related]  

  • 12. Has the circulating permeability factor in primary FSGS been found?
    Jefferson JA; Shankland SJ
    Kidney Int; 2013 Aug; 84(2):235-8. PubMed ID: 23903418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hype cycle for soluble urokinase receptor in FSGS: passing the trough of disillusionment?
    Meijers B; Sprangers B
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1835-6. PubMed ID: 25318753
    [No Abstract]   [Full Text] [Related]  

  • 14. The authors reply.
    Huang J; Zhao MH
    Kidney Int; 2014 Mar; 85(3):711-2. PubMed ID: 24583990
    [No Abstract]   [Full Text] [Related]  

  • 15. The authors reply:
    Huang J; Cui Z; Zhao MH
    Kidney Int; 2014 Jun; 85(6):1470-1. PubMed ID: 24875553
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary and Recurrent Focal Segmental Glomerulosclerosis Closely Link to Serum Soluble Urokinase-type Plasminogen Activator Receptor Levels.
    Jin J; Li YW; He Q
    Transplant Proc; 2015; 47(6):1760-5. PubMed ID: 26293047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation.
    Cara-Fuentes G; Araya C; Wei C; Rivard C; Ishimoto T; Reiser J; Johnson RJ; Garin EH
    Nefrologia; 2013; 33(5):727-31. PubMed ID: 24089165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis.
    Huang J; Liu G; Zhang YM; Cui Z; Wang F; Liu XJ; Chu R; Chen Y; Zhao MH
    Kidney Int; 2013 Aug; 84(2):366-72. PubMed ID: 23447064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circulating permeability factors in primary focal segmental glomerulosclerosis].
    Wada T; Nangaku M
    Nihon Jinzo Gakkai Shi; 2014; 56(4):478-85. PubMed ID: 24956879
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis].
    Segarra A; Jatem E; Quiles MT; Arbós MA; Ostos H; Valtierra N; Carnicer C; Salcedo MT
    Nefrologia; 2014; 34(1):53-61. PubMed ID: 24463863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.